Gilead Sciences sets aside $200 million to resolve HIV drug probe
|
... settlement with federal prosecutors to resolve an
investigation into the drugmaker's promotional speakers program for HIV
drugs. |
Gilead's lenacapavir applications for HIV gain EMA validation
Gilead's lenacapavir gained approval in several nations for treating the adult population with multi-drug resistant HIV in conjunction with other ... View article...